Related Experiment Videos
[Low intensity anticoagulation therapy after mechanical heart valve replacement]
Li Dong1, Ying-kang Shi, Zi-pu Tian
1Department of Cardiothoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|July 29, 2003
Summary
This study found that lower intensity anticoagulation therapy, specifically an International Normalized Ratio (INR) of 1.5-2.0 and a Prothrombin Time Ratio (PTR) of 1.3-1.5, is safer for patients with mechanical heart valves in China. This approach reduces hemorrhage risks and improves outcomes for pregnant women and newborns.
Area of Science:
- Cardiovascular Surgery
- Pharmacology
- Clinical Medicine
Context:
- Mechanical heart valve replacement is a critical procedure.
- Effective anticoagulation is essential post-surgery to prevent thrombosis and embolism.
- China faces unique challenges in managing anticoagulation therapy.
Purpose:
- To determine the optimal anticoagulation intensity for Chinese patients after mechanical heart valve replacement.
- To evaluate the relationship between anticoagulation intensity and complication rates.
Summary:
- A study of 480 patients revealed that the primary complication of anticoagulation therapy is hemorrhage.
- Lower anticoagulation intensity (INR 1.5-2.0, PTR 1.3-1.5) significantly reduced hemorrhage rates and deaths.
- Thromboembolism rates were low, and no malformed newborns were observed in 15 pregnancies.
Impact:
- Establishing proper anticoagulation targets can decrease mortality and morbidity.
- Low-intensity anticoagulation therapy benefits pregnant women and newborns, preventing hemorrhage and malformations.
- Improved anticoagulation management enhances the overall quality of life for patients with mechanical heart valves.